Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement
结核分枝杆菌分子耐药性检测的临床意义:2023 年 TBnet/RESIST-TB 共识声明
期刊:Lancet Infectious Diseases
影响因子:31
doi:10.1016/S1473-3099(22)00875-1
Domínguez, José; Boeree, Martin J; Cambau, Emmanuelle; Chesov, Dumitru; Conradie, Francesca; Cox, Vivian; Dheda, Keertan; Dudnyk, Andrii; Farhat, Maha R; Gagneux, Sebastien; Grobusch, Martin P; Gröschel, Matthias I; Guglielmetti, Lorenzo; Kontsevaya, Irina; Lange, Berit; van Leth, Frank; Lienhardt, Christian; Mandalakas, Anna M; Maurer, Florian P; Merker, Matthias; Miotto, Paolo; Molina-Moya, Barbara; Morel, Florence; Niemann, Stefan; Veziris, Nicolas; Whitelaw, Andrew; Horsburgh, Charles R Jr; Lange, Christoph